Impact of prescribing nonsteroidal anti-inflammatory drugs in pleurodesis surgery after pneumothorax: a prospective randomized controlled double-blind multicenter noninferiority study
- Conditions
- pleurodesis surgery for cure of pneumothoraxTherapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
- Registration Number
- CTIS2024-511226-32-00
- Lead Sponsor
- Centre Hospitalier Universitaire Amiens Picardie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Recruiting
- Sex
- All
- Target Recruitment
- 358
Pneumothorax for video-exclusive surgical indication With or without minor lung resection (atypical resection), Age > or = 18 years old, Written or oral informed consent to participate in the study., Affiliation to a social security scheme, Highly effective contraception for women of childbearing age (combined hormonal contraception (estrogen and progesterone) combined with ovulation inhibition (oral, intra-vaginal, transdermal), hormonal contraception (progesterone only) combined with ovulation inhibition (oral, injectable, implantable), intrauterine device, hormone-releasing intrauterine system, bilateral fallopian tube occlusion, vasectomized partner, sexual abstinence, etc.). )
Minor, Patient under guardianship, curatorship or deprived of liberty, patient who refuses to participate in the study, Contraindication to the use of NSAIDs, Contraindications to the use of TRAMADOL, Curative anticoagulation, Contraindications to the use of NEFOPAM, Contraindications to the use of PARACETAMOL, Contraindications to the use of SODIUM CHLORIDE, Lactose intolerance, Hemopneumothorax, Purulent pleurisy, Polytraumatized, Pregnant, parturient or breastfeeding patient
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method